Filing Details

---

 

 

* Based upon 10,192,416 shares of Common Stock issued and outstanding on November 3, 2022 as reflected in the Form 10-Q of the Issuer for the quarterly period ended September 30, 2022, filed on November 8, 2022. See Item 4.

* Based upon 10,192,416 shares of Common Stock issued and outstanding on November 3, 2022 as reflected in the Form 10-Q of the Issuer for the quarterly period ended September 30, 2022, filed on November 8, 2022. See Item 4.

 

* Based upon 10,192,416 shares of Common Stock issued and outstanding on November 3, 2022 as reflected in the Form 10-Q of the Issuer for the quarterly period ended September 30, 2022, filed on November 8, 2022. See Item 4.

 Item 1(a): Name of Issuer:

 

Indus Realty Trust, Inc. (the “Issuer”).

 

Item 1(b): Address of Issuer’s Principal Executive Offices:

 

641 Lexington Avenue, New York, NY 10022.

Item 2(a): Name of Person Filing:

 

This Schedule 13G is filed by:

   

(i) Monarch Alternative Capital LP (“MAC”), which serves as advisor to a variety of funds (such funds collectively, the “Funds”), with respect to shares of Common Stock of the Issuer directly owned by the Funds;

 

(ii) MDRA GP LP (“MDRA GP”), which is the general partner of MAC, with respect to shares of Common Stock indirectly beneficially owned by virtue of such position; and

 

(v) Monarch GP LLC (“Monarch GP”), which is the general partner of MDRA GP, with respect to shares of Common Stock indirectly beneficially owned by virtue of such position.

 

MAC, MDRA GP and Monarch GP are sometimes collectively referred to herein as the “Reporting Persons.”

 

Item 2(b): Address of Principal Business Office or, if None, Residence:

 

The address of the principal business office of the Reporting Persons is as follows:

 

c/o Monarch Alternative Capital LP

535 Madison Avenue

New York, New York 10022

Item 2(c): Citizenship:

 

MAC is a Delaware limited partnership. MDRA GP is a Delaware limited partnership. Monarch GP is a Delaware limited liability company.

 

Item 2(d): Title of Class of Securities:

 

Common Stock, par value $0.01 per share  (“Common Stock”).

 

Item 2(e): CUSIP Number

 

45580R103

Item 3: If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:

 

 

 

 

 

 

 

 

 

 

 

Item 4: Ownership:

 

The beneficial ownership of each of the Reporting Persons as of December 31, 2019 is as follows: 

 

A. MAC

 

(a) Amount beneficially owned: 714,000

 

(b) Percent of Class: 7.01%

 

(c) Number of shares as to which such person has:

 

(i) Sole power to vote or direct the vote: 0

 

(ii) Shared power to vote or direct the vote: 714,000

 

(iii) Sole power to dispose or direct the disposition: 0

 

(iv) Shared power to dispose or direct the disposition: 714,000

B. MDRA GP

 

(a)	Amount beneficially owned: 714,000

(b) Percent of Class: 7.01%

(c) Number of shares as to which such person has:

(i) Sole power to vote or direct the vote: 0

 

(ii) Shared power to vote or direct the vote: 714,000

(iii) Sole power to dispose or direct the disposition: 0

 

(iv) Shared power to dispose or direct the disposition: 714,000

 

C. Monarch GP

 

(a) Amount beneficially owned: 714,000

 

(b) Percent of Class: 7.01%

 

(c) Number of shares as to which such person has:

 

(i) Sole power to vote or direct the vote: 0

 

(ii) Shared power to vote or direct the vote: 714,000

 

(iii) Sole power to dispose or direct the disposition: 0

 

(iv) Shared power to dispose or direct the disposition: 714,000

The foregoing beneficial ownership amounts and corresponding percentages are based upon 10,192,416 shares of Common Stock issued and outstanding on November 3, 2022 as reflected in the Form 10-Q of the Issuer for the quarterly period ended September 30, 2022, filed on November 8, 2022.

Item 5: Ownership of Five Percent or Less of a Class:

 

N/A

 

Item 6: Ownership of More than Five Percent on Behalf of Another Person:

 

N/A

 

Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

 

See Exhibit 99.1

Item 8: Identification and Classification of Members of the Group:

 

N/A

 

Item 9: Notice of Dissolution of Group:

 

N/A

 

Item 10: Certification:

 

By signing below the signatory certifies that, to the best of his knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.